GO
Loading...

Pfizer Inc

More

  • Bank Of America Continues Monday Woes Monday, 21 Apr 2008 | 9:37 AM ET

    Monday has not been a great day for bank earnings. Last Monday it was Wachovia that disappointed, today futures dropped at 7 am ET as Bank of America came short of expectations.

  • Week Ahead: The Big Test Friday, 18 Apr 2008 | 8:09 PM ET

    Whenever the stock market rushes full speed ahead, it is hard not to look for the big let-down. That could be the case in the week ahead... Major earnings reports, housing data, annual shareholder meetings, and Tuesday's Pennsylvania presidential primaries are what traders will be watching to see if the trend continues.

  • Bitter Pill? Friday, 18 Apr 2008 | 6:28 PM ET

    Was Pfizer's miss, a prescription for disaster in Big Pharma? Should you sell drug makers ahead of earnings next week?

  • Springtime for Pharma: A Big Week Ahead For Earnings Friday, 18 Apr 2008 | 12:01 PM ET

    The irreverent producers of "Squawk on the Street" who are stationed in the pod next to mine here at CNBC like to call it "Pharmapalooza." They're referring to weeks like the one coming up when nearly every big drug company reports earnings.

  • Stocks Flat But Earnings News Abound Thursday, 17 Apr 2008 | 7:09 PM ET

    Google hits it out of the park, Merrill posts a loss but shares climb anyway and Pfizer plummets. All the earnings trades and much more right here.

  • The Case For Being Bullish Thursday, 17 Apr 2008 | 4:37 PM ET

    Futures popped right after the close as Google reported strong numbers; up 10 percent. Major indices stable today, despite mixed earnings report. IBM, good, Marriott, ok on strong international sales, but Conway, Nokia and Pfizer were notable disappointments.

  • Stocks Finish Flat; Financials Rebound Thursday, 17 Apr 2008 | 4:26 PM ET

    Stocks wobbled Thursday as investors digested a mixed bag of earnings and economic news. IBM was the biggest gainer on the Dow, while Pfizer was the biggest decliner.

  • Pfizer, UTX Drag on Dow; Merrill Rises Thursday, 17 Apr 2008 | 3:18 PM ET

    Stocks wobbled Thursday as investors digested a mixed bag of earnings and economic news. IBM was the biggest gainer on the Dow, while Pfizer was the biggest decliner.

  • Pfizer's "Crown Jewel" Lipitor: Has It Lost Its Value? Thursday, 17 Apr 2008 | 12:12 PM ET
    Lipitor

    The world's biggest drug company kicked off pureplay pharma earnings season this morning with disappointing results that look to be dragging down the whole sector. PFE missed Wall Street expectations on revenue and profits.

  • Dow Wobbles as IBM Jumps, Pfizer Falls Thursday, 17 Apr 2008 | 12:09 PM ET

    Stocks wobbled Thursday as investors digested a mixed bag of earnings and economic news. IBM was the biggest gainer on the Dow, while Pfizer was the biggest decliner.

  • Nokia and Pharma Drag Euro Stocks Lower Thursday, 17 Apr 2008 | 11:45 AM ET

    European shares fell on Thursday, led lower by Nokia after the world's biggest maker of mobile phones failed to impress investors with its outlook, dragging down other technology and telecom stocks.

  • Stocks Waver as Market Digests Earnings Thursday, 17 Apr 2008 | 10:46 AM ET

    Stocks were lower Thursday as investors digested a mixed bag of earnings and a better-than-expected report on weekly jobless claims.

  • Pfizer Profit Slips, Hurt by Generic Drugs Thursday, 17 Apr 2008 | 9:40 AM ET

    Pfizer on Thursday reported a worse-than-expected decline in first-quarter earnings after declining sales of cholesterol fighter Lipitor and medicines now facing generic competition, sending shares down almost 4 percent.

  • Earnings Not Much Help For Markets Thursday, 17 Apr 2008 | 9:13 AM ET

    Mixed reports on earnings this morning; IBM is a help, but Pfizer, Continental Airlines, Marriottspacer and Nokia are not. Merrill Lynch recorded another $9 b in write-downs on mortgage-related assets, leveraged loans and hedges.

  • Market Insider/Thursday Look Ahead Wednesday, 16 Apr 2008 | 10:00 PM ET

    IBM's big 26 percent profit jump could set the foundation for another decent day in the market if there are no nasty surprises in the wings to derail it. 

  • Pfizer's Pipeline Play Wednesday, 16 Apr 2008 | 6:19 PM ET

    Ahead of earnings Thursday, Pfizer announced plans to license a brain cancer drug from Avant Immunotherapeutics. Will Pfizer continue to buy its way to a promising drug pipeline?

  • Bobby Murcer as New York Yankees broadcaster

    The world's biggest pharma company is stepping up to the plate again. After the closing bell today PFE announced it's doing a deal worth up to $440 million over time with a baby biotech called Avant Immunotherapeutics.

  • Trader Radar - Tuesday, Apr. 15th Tuesday, 15 Apr 2008 | 5:42 PM ET

    Q: On Fast Money's Trader Radar we look at the stock that was lighting up screens across Wall Street today. Its much-lauded little blue pill hasn't been able to prop up shares this year, as the stock flags in the face of pipeline problems and generic competition. But after setbacks for a competitor's cholesterol drug, investors are betting Thursday's earnings report will show stronger Lipitor sales for the world's biggest drugmaker. Who is it?

  • Johnson & Johnson's Earnings And Its Very "Taxing" Day Tuesday, 15 Apr 2008 | 3:56 PM ET
    Johnson & Johnson

    Dow component and healthcare conglomerate (drugs, consumer products, medical devices) Johnson & Johnson beat and boosted. That's Wall Street jargon for earnings coming in higher than expectations and the guidance for the rest of the year being raised. So, why did the stock go down?

  • AstraZeneca Shares Leap on Nexium Settlement Deal Tuesday, 15 Apr 2008 | 5:50 AM ET

    AstraZeneca has settled U.S. patent litigation against India's Ranbaxy Laboratories over its top-selling drug, ulcer pill Nexium, securing future sales and sending its shares soaring.